世界盃百萬美元套房背後:SoFi工人為租金與安全抗爭,罷工威脅籠罩洛杉磯

(SeaPRwire) -   By: Robert Sterling 世界盃本該是場慶典,但SoFi體育場的基層員工卻在為生存掙扎。負責餐飲服務的Legends Global靠這場賽事賺取利潤,卻虧待2000名調酒師、服務生、廚師與洗碗工——正是這些人讓體育場得以運轉。這不只是勞資糾紛,更是大型賽事是否重視基層員工的考驗。 Legends聲稱與工會有長期合作關係,並承諾透過談判達成協議。但背後真相很清楚:談判進度極為緩慢。公司只願給廚師與洗碗工小幅加薪,卻凍結套房服務員與調酒師的薪資。儘管世界盃將帶來鉅額收益,Legends仍不願讓步於基本保障——比如保護員工免於分包或移民執法突襲。 員工已投票授權罷工。他們可能在6月12日美國對巴拉圭的首場比賽當天離開崗位。工會共同主席Kurt Petersen直言:「如果工人付不起房租,或上班時害怕被ICE抓走,世界盃對洛杉磯有什麼意義?」亞特蘭大、邁阿密等其他主辦城市的社團也呼籲比賽期間暫停移民執法。終身足球迷、調酒師Cesar Zamora雖心碎,但為了尊嚴願意罷工。 如果Legends不儘快達成協議,世界盃的餐飲混亂將損害其品牌。未來大型賽事在僱用無法在關鍵時刻讓員工滿意的公司前,會三思而行。 Author bio: Robert Sterling,擁有數十年實體經濟產業投資與擴張經驗的海外創業資深人士。

GA-ASI Announces Investments in Six Dutch Companies

SAN DIEGO, June 9, 2026 - (ACN Newswire via SeaPRwire.com) - General Atomics Aeronautical Systems, Inc. (GA‑ASI) is deepening its footprint in the Dutch innovation ecosystem, with new investments in six Netherlands-based technology companies through its Blue Magic Netherlands (BMN) venturing initiative.These new partnerships follow the latest BMN event in Eindhoven, a fast-paced, "shark tank"-style forum in which Dutch startups and scaleups pitched breakthrough technologies directly to GA‑ASI decision makers. The most recent edition drew more than 350 attendees from across the country's aerospace, defense, and high-tech communities.Building on the success of prior events, GA‑ASI has selected six Dutch companies for new investment and collaboration. GA-ASI also is increasing its investment in Emergent Swarm, first discovered at BMN 2024. Emergent Swarm is partnering with GA‑ASI to further mature its swarming autonomy detection capability."Blue Magic Netherlands is our window into the Dutch innovation ecosystem," said Brad Lunn, Managing Director, GA‑ASI. "We are not just scouting ideas. We are deploying capital, engineering resources, and access to platforms to help these companies scale. We're making these new investments because it is clear to us that the Netherlands is one of the most dynamic technology hubs in Europe."The six new GA‑ASI portfolio companies are:OPT/NET B.V. - GA-ASI, alongside its GA-Intelligence affiliate, will be working with OPT/NET to explore collaboration opportunities for a variety of AI-related missions, including drone swarm management and dark vessel detection.Vaeridion B.V. - GA-ASI will be working with Vaeridion to evaluate their advanced battery pack technology for use in current and future GA-ASI platforms.Touchwaves B.V. - GA-ASI will be evaluating Touchwaves' haptic technology for use in remotely piloted UAS environments to determine the potential benefits to long-duration missions and aircrew information overload.FDCL Defence B.V. - GA-ASI and GA-Intelligence will be working with Fiducial to explore the effectiveness of the company's technology toward massively scaled low-cost future platforms.Vydar Commercial B.V. - GA-ASI will evaluate Vydar's technology in a variety of relevant GPS-denied environments and GA-ASI and GA-EMS platforms.Emproof B.V. - GA-ASI will evaluate the effectiveness of Emproof's data protection technology for applicability to current and future GA-ASI platforms.GA‑ASI expects to announce additional investments from the 2025 BMN cohort in the coming months, as technical evaluations and co‑development discussions progress.About Blue Magic VenturesBlue Magic Ventures is GA‑ASI's corporate venturing initiative, designed to identify, invest in, and scale breakthrough technologies from startups and innovators around the world. Through capital investment, access to platforms, and deep technical collaboration, Blue Magic Ventures accelerates the path from concept to capability for dual‑use technologies.About GA-ASIGeneral Atomics Aeronautical Systems, Inc., is the world's foremost builder of Unmanned Aircraft Systems (UAS). Logging more than 9 million flight hours, the Predator® line of UAS has flown for over 30 years and includes MQ-9A Reaper®, MQ-1C Gray Eagle®, MQ-20 Avenger®, and MQ-9B SkyGuardian®/SeaGuardian®. The company is dedicated to providing long-endurance, multi-mission solutions that deliver persistent situational awareness and rapid strike.For more information, visit www.ga-asi.com.Avenger, EagleEye, Gray Eagle, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are trademarks of General Atomics Aeronautical Systems, Inc., registered in the United States and/or other countries.GA-ASI Media RelationsGeneral Atomics Aeronautical Systems, Inc.ASI-MediaRelations@ga-asi.com(858) 524-8101SOURCE: General Atomics Aeronautical Systems, Inc. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

GA-ASI 宣布投資六家荷蘭企業

加州聖地牙哥, 2026年6月9日 - (亞太商訊 via SeaPRwire.com) - 通用原子航空系統公司(GA ASI)正透過其「藍魔力荷蘭」(BMN)創投計畫,對六家總部位於荷蘭的科技公司進行新投資,藉此深化其在荷蘭創新生態系統中的佈局。這些新夥伴關係源於在埃因霍溫舉辦的最新一屆「藍魔力荷蘭」活動。該活動採用快節奏的「創投大鯊魚」風格論壇形式,讓荷蘭新創企業與成長型企業能直接向GA ASI決策者展示其突破性技術。本屆活動吸引了來自全國航空航天、國防及高科技領域的超過350名與會者。基於過往活動的成功經驗,GA ASI已選定六家荷蘭企業進行新投資與合作。GA-ASI 同時也將增加對 Emergent Swarm 的投資,該公司最初是在 2024 年 BMN 活動中被發掘的。Emergent Swarm 正與 GA ASI 合作,以進一步完善其群體自主偵測能力。「Blue Magic Netherlands 是我們窺探荷蘭創新生態系的窗口,」GA ASI 董事總經理 Brad Lunn 表示。「我們不僅在發掘創意,更投入資金、工程資源及平台管道,協助這些企業擴大規模。我們之所以進行這些新投資,是因為我們清楚地看到,荷蘭是歐洲最具活力的科技樞紐之一。」GA ASI 旗下六家新投資企業如下:OPT/NET B.V. — GA-ASI 將與旗下子公司 GA-Intelligence 攜手,與 OPT/NET 合作探索各項 AI 相關任務的合作機會,包括無人機群管理與暗色船隻偵測。Vaeridion B.V. — GA-ASI 將與 Vaeridion 合作,評估其先進電池組技術在 GA-ASI 現有及未來平台中的應用潛力。Touchwaves B.V. — GA-ASI 將評估 Touchwaves 的觸覺技術在遙控無人機系統(UAS)環境中的應用,以確定該技術對長時間任務及緩解飛行員資訊過載的潛在效益。FDCL Defence B.V. - GA-ASI 與 GA-Intelligence 將與 Fiducial 合作,探討該公司技術在未來大規模低成本平台上的有效性。Vydar Commercial B.V. - GA-ASI 將在各種相關的 GPS 受限環境中,以及 GA-ASI 與 GA-EMS 平台上評估 Vydar 的技術。Emproof B.V. - GA-ASI 將評估 Emproof 的資料保護技術,以確認其適用於現有及未來的 GA-ASI 平台。隨著技術評估與共同開發討論的推進,GA-ASI 預計將於未來數月內宣布 2025 年 BMN 投資組的更多投資項目。關於 Blue Magic VenturesBlue Magic Ventures 是 GA-ASI 的企業創投計畫,旨在發掘、投資並擴展來自全球新創公司與創新者的突破性技術。透過資本投資、平台資源及深度技術合作,Blue Magic Ventures 加速雙用技術從概念到實用能力的發展進程。關於 GA-ASI通用原子航空系統公司(General Atomics Aeronautical Systems, Inc.)是全球首屈一指的無人機系統(UAS)製造商。「捕食者®」(Predator®)系列無人機系統累積飛行時數已超過 900 萬小時,服役逾 30 年,包含 MQ-9A「死神®」(Reaper®)、MQ-1C「灰鷹®」(Gray Eagle®)、MQ-20「復仇者®」(Avenger®)以及 MQ-9B「天衛®」(SkyGuardian®)/「海衛®」(SeaGuardian®)。該公司致力於提供長航時、多任務解決方案,以實現持續的戰場態勢感知與快速打擊能力。欲了解更多資訊,請造訪 www.ga-asi.com 。Avenger、EagleEye、Gray Eagle、Lynx、Predator、Reaper、SeaGuardian 及 SkyGuardian 均為通用原子航空系統公司(General Atomics Aeronautical Systems, Inc.)於美國及/或其他國家註冊的商標。GA-ASI 媒體關係通用原子航空系統公司ASI-MediaRelations@ga-asi.com (858) 524-8101消息來源:通用原子航空系統公司 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

高收入群体也沦陷!美国生活成本危机下的消费怪象

(SeaPRwire) -By: Logan Pierce 美国生活成本危机肆虐,连高收入者都撑不住。沃尔玛CEO约翰·弗纳透露,高收入顾客正更多涌入沃尔玛,见面多了、买得多了、来得勤了。当下经济中,沃尔玛低收入顾客压力更重,可六位数收入者也因油价、关税等因素转向折扣店。食品成本疯涨,冷萃咖啡价5月来涨3.7%,汉堡涨2.4%,牛肉等 essentials 价格飙升。超75%人减其他开支买 groceries,Dollar General CEO说顾客缩减食品等消费。超七成六位数收入者逛折扣店省钱,还缩减餐饮、娱乐等消费。"收入不保财务安心", Clarify Capital报告点出现实。 Author bio: Logan Pierce, independent business writer keen on dissecting real-world economic trends.

Mazda Advances Toward Commercialization of Onboard CO2 Capture System

HIROSHIMA, Japan, June 8, 2026 - (JCN Newswire via SeaPRwire.com) - Mazda Motor Corporation (Mazda) conducted a demonstration test of its under development onboard COâ‚‚ (carbon dioxide) capture system, ‘Mazda Mobile Carbon Capture,’ during Round 3* of the Super Taikyu Series 2026, held from June 5 to 7, 2026. During the test, Mazda successfully demonstrated COâ‚‚ storage during driving, newly added to this round of testing, marking a step forward toward the practical application of the system and the achievement of carbon negativity.Under the theme “The Joy of Driving Fuels a Sustainable Tomorrow,” Mazda announced “Mazda Mobile Carbon Capture” at last year’s JAPAN MOBILITY SHOW 2025, and is aiming to realize mobility that reduces COâ‚‚ the more you drive by 2035.In this demonstration test, a COâ‚‚ desorption function of the adsorption unit and a COâ‚‚ storage tank were added to the race car “MAZDA SPIRIT RACING 3 Future concept” (No. 55), which was driven using carbon-neutral fuel—hydrotreated vegetable oil (HVO) which is already in practical use in Europe. As in the previous test, zeolite with a porous structure was employed as the adsorbent. Zeolite readily releases COâ‚‚ when heated, enabling the captured COâ‚‚ to be desorbed using the exhaust heat generated during driving. The desorbed COâ‚‚ is then compressed by an electric compressor and stored in a tank. Mazda has successfully demonstrated this integrated process as a complete system for the first time. As a result of repeating this process throughout the 24-hour race, a total of 804 grams of COâ‚‚ was captured, achieving a significant advancement—approximately 9.6 times the previous result of 84 grams.In addition to the storage experiment, the combined effect of COâ‚‚ reduction achieved through HVO and the amount of COâ‚‚ captured by the system temporarily exceeded the target recovery level assumed for typical use of Mazda production vehicles, confirming the potential for carbon-negative operation in production vehicles, albeit for a limited period. Building on these results, Mazda is embarking on a new phase of challenges aimed at achieving carbon negativity in racing cars, which operate under higher loads and more demanding conditions. Specifically, Mazda aims to achieve short-term carbon negativity in its racing car at Round 7 of the Super Taikyu Series, to be held this November.Moving forward, Mazda will continue to collaborate with numerous partners to further refine the technology and equipment based on the insights gained to date, contributing to the realization of a sustainable mobility society.Related News Releases- Mazda Begins Demonstration Experiment of Onboard COâ‚‚ Capture Systemhttps://newsroom.mazda.com/en/publicity/release/2025/202511/251117b.htmlRelated information: Mazda Corporate WebsiteMAZDA MIRAI BASE- Japan Mobility Show 2025: The Joy of Driving Fuels a Sustainable Tomorrow. Mazda’s Vision for the Future of Smart Mobility in 2035https://www.mazda.com/en/mazda-mirai-base/articles/20251029-jms2025-concept/- Japan Mobility Show 2025: The More You Drive, the Cleaner the Planet? The MAZDA VISION X-COUPE and the Future of Joy of Drivinghttps://www.mazda.com/en/mazda-mirai-base/articles/20251029-jms2025-mazda-vision-xcoupe/- Creating a Positive Future for Combustion Engine Cars: Mazda’s Public Proof-of-Concept Testing for Carbon Neutral Combustion Engine Carhttps://www.mazda.com/en/mazda-mirai-base/articles/20251210-CO2-capture/MAZDA SPIRIT RACING- Super Taikyu Series: One of Japan’s premier endurance racing series featuring a wide range of vehicle models: (Japanese only)https://www.mazda.com/ja/experience/mspr/motorsports/supertaikyu/* ENEOS Super Taikyu Series 2026 Empowered by BRIDGESTONE Round 3: Fuji 24-Hour Race  Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

Collaboration Between OCTARVIA Programs and MiPoLin(R)

TOKYO, June 8, 2026 - (JCN Newswire via SeaPRwire.com) - National Maritime Research Institute (NMRI), National Institute of Maritime, Port and Aviation Technology and Mitsubishi Shipbuilding Co., Ltd., a part of the Mitsubishi Heavy Industries (MHI) Group, have begun integrating the "OCTARVIA" programs developed by NMRI to evaluate and analyze ship performance in actual seas with the "MiPoLin®" power prediction and lines selection system developed by Mitsubishi Shipbuilding.The OCTARVIA programs (the ship lifecycle fuel efficiency evaluation program "OCTARVIA-web V2.1" and the actual ship monitoring data analysis program "SALVIA-OCT.-web V2.2"), which are released on NMRI cloud on June 5, 2026, allow users to import hull geometry and performance data generated by MiPoLin® into the OCTARVIA programs, enabling seamless execution of ship lifecycle fuel consumption estimates and ship performance evaluations based on ship monitoring data.Through this collaboration, NMRI and Mitsubishi Shipbuilding will promote dissemination of OCTARVIA programs and MiPoLin® and thereby support efforts to reduce greenhouse gas emissions in the maritime sector.NMRI is currently working to enhance the functionality of the following programs developed under the Japan Maritime Cluster Collaborative Research Project on Evaluation of Ship Performance in Actual Seas (OCTARVIA) with the aim of social implementation:Program for estimating ship lifecycle fuel consumption (OCTARVIA-web)Program for onboard monitoring data analysis (SALVIA-OCT.-web)Program for providing ship form and ship performance data from the principal dimensions (EAGLE-OCT.-web)-an input support tool for OCTARVIA-web and SALVIA-OCT.-web-Mitsubishi Shipbuilding has developed "MiPoLin®" , a user-friendly, highly accurate power prediction and lines selection system that leverages over 1,200 tank test results accumulated over more than 100 years at the Mitsubishi Nagasaki Experimental Tank, as well as data from more than 420 ship designs. The company provides this system to enable Mitsubishi Heavy Industries Group's technologies to be widely utilized in solving problems across the entire maritime industry.To enhance the input support for OCTARVIA-web and SALVIA-OCT.-web, NMRI added an integration functionality with the MiPoLin® to the previous version of the programs. On June 5, 2026, NMRI is releasing OCTARVIA-web V2.1 and SALVIA-OCT.-web V2.2 on the NMRI cloud.This functionality enables users not only to estimate hull geometry and performance based on ship principal particulars, as was previously possible, but also to seamlessly integrate ship databases and tank test databases into the OCTARVIA programs. This allows shipping companies and other organizations to perform more accurate estimates of ship lifecycle fuel consumption and analyze onboard monitoring data.Through these programs, NMRI and Mitsubishi Shipbuilding will promote the reduction of GHG emissions from the maritime sector.(Annex)Collaboration Between OCTARVIA Programs and MiPoLin® (547 KB)About MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

TON Corporation to Launch ‘TonTV’, a Telegram-Native Short-Drama Platform, Globally in September 2026

A binge-watchable library of two-minute vertical dramas — free, no app-store install, opened from a single Telegram account for the platform’s ~1 billion monthly users. HO CHI MINH, VIETNAM – June 08, 2026 – (SEATribune) – Global content-tech company TON Corporation (CEO Henry Kim) today announced that it will officially launch ‘TonTV’, its Telegram-native short-drama platform, worldwide in September 2026. TonTV lets the ~1 billion people who use Telegram each month instantly and freely watch short dramas with a single Telegram account — with no separate app install and no complicated sign-up. Short drama is one of entertainment’s fastest-rising categories Short-form drama has moved to the center of global media consumption. Global in-app revenue for short dramas reached $2.98 billion in 2025, up 115% year over year, and in Q4 2025 short-form titles overtook long-form streaming apps in downloads for the first time (733M vs. 658M), according to Sensor Tower and Omdia. With short runtimes, high completion rates, and mobile-first immersion, the format is growing fastest among younger viewers. TonTV places dramas of around two minutes at the heart of this trend — short but intense chapters that build a “can’t-stop-once-you-start” experience. The Telegram Mini App: tearing down the barrier to entry TonTV’s core strength is that it runs atop Telegram, a massive global platform. Existing OTT services require a long entry sequence — app-store search → download → install → sign-up → enter payment details. TonTV removes it: open the Mini App inside Telegram → watch instantly, for free. The user reach that global OTT leaders such as Netflix and Disney+ built over years and at enormous cost is something TonTV can address from day one, across Telegram’s ~1 billion monthly users. This dramatically lowers user-acquisition cost while driving early growth through natural word-of-mouth across Telegram’s groups and channels. Three years of preparation, and “why we can win” TonTV did not appear overnight. Over the past three years, TON Corporation has focused on platform-technology development, global content partnerships, and a local-operations model in preparation for launch. CTO Tony cited the following reasons TonTV can be a market “game changer” rather than a late follower: • Frictionless reach — among the first specialized short-drama platforms to reach Telegram’s ~1 billion monthly users, free, in one click • Free entry — anyone can start at no cost, a strong advantage for early user acquisition • Network effects — discussion, sharing, and recommendation happen at the same moment as viewing • Viewer-participation rewards — enjoying content itself returns benefits and rewards, building loyalty • Simultaneous global release — worldwide at once, with no region-by-region app-store approval On these strengths, TonTV aims to grow beyond short drama into real-time formats such as live streaming over time. A ‘new stage’ for producers, actors, and staff worldwide TonTV goes beyond a viewing platform to open opportunity for the global content industry. Producers can showcase work directly to a global audience; actors and staff can widen their stage across borders. For emerging teams and new actors who have struggled to get a chance at traditional broadcasters or large OTTs, TonTV offers an open stage judged on ability — creating jobs across planning, production, acting, and post-production. “Global one platform, local content” TonTV places local subsidiaries in major markets — Korea, Japan, Vietnam, India, Indonesia, and the Philippines — planning and producing content suited to each region’s culture on the ground. Combining a global platform’s scale with local content’s intimacy, TonTV aims to be a true global OTT where anyone can enjoy “stories from home.” The local-subsidiary model expands content and markets quickly while keeping head-office cost low. A dual revenue model: “growth and profit together” TonTV operates a dual model: a free, ad-supported tier where all users watch at no cost, and a premium subscription for an ad-free experience. Advertiser acquisition and content production through local subsidiaries create a cycle in which ad and subscription revenue grow with the user base. Telegram’s low acquisition cost and short-form’s high completion rates support this model. Comment from TON Corporation CTO Tony CTO Tony said: “For the past three years we’ve focused everything on creating the easiest, most enjoyable way to watch drama. On Telegram — a playground of a billion people — TonTV sets a new standard for short drama anyone can enjoy free, with a single account.” He added: “TonTV will create the best experience for viewers, a new stage for creators, and new jobs for the industry — and our ambition is to become the global leader in short-drama and live content.” Future plans From its September 2026 launch, TonTV plans to rapidly expand its content lineup and service regions, broaden from short drama into real-time formats such as live streaming, and accelerate global expansion through its local subsidiaries. About TON Corporation TON Corporation is a global content-tech company headquartered in Ho Chi Minh, Vietnam. Through TonTV, its Telegram-native short-drama platform, it aims to deliver a new entertainment experience to users worldwide and open opportunity for global content creators. Media Contact Brand: TON Corporation Contact: PR Team Email: press@toncorp.io Website: https://tontv.toncorp.io Telegram: https://t.me/TontvOfficialChannel

Hitachi joins Anthropic’s “Project Glasswing” an AI-powered security program

TOKYO, June 8, 2026 - (JCN Newswire via SeaPRwire.com) - Hitachi, Ltd. (TSE:6501, "Hitachi") has entered into an agreement to join “Project Glasswing*1” led by Anthropic PBC (“Anthropic”). “Project Glasswing” is a collaborative initiative designed to safeguard the world’s most critical software and to advance the cybersecurity practices required of the industry as AI continues to evolve. Under the agreement, Hitachi will gain access to the frontier AI model, “Claude Mythos Preview” (“Mythos”), and will use it to strengthen the cybersecurity of Hitachi's own software and products for the social infrastructure sector, including the energy domain.*1 Announced by Anthropic on June 2, 2026 Expanding Project GlasswingHitachi is driving innovation in social infrastructure through the practical application of Physical AI by integrating data generated from its globally deployed IT, OT (operational technology), and products with over 110 years of accumulated domain expertise. As AI becomes increasingly embedded in real-world infrastructure and operational environments, ensuring an exceptionally high level of safety and reliability has become essential. Against the backdrop, Hitachi recently announced a strategic partnership with Anthropic, the provider of the frontier AI model “Claude,” which has a strong track record in enterprise applications.*2 Through thecollaboration, the two companies have initiated efforts toward the safe social implementation of Physical AI.*2 Press release dated May 19, 2026 Hitachi announces strategic partnership with Anthropic to strengthen "Lumada 3.0" through frontier AIIn addition to the above collaboration, our participation in “Project Glasswing,” aims to enhance AI-driven cyberdefense and protect critical infrastructure worldwide. Hitachi’s Cyber Center of Excellence will use Mythos Preview to identify and remediate vulnerabilities in the software that Hitachi builds and maintains for social infrastructure, including the energy domain. Through this work, Hitachi will contribute to the realization of safe, secure, and resilient social infrastructure.About Hitachi, Ltd.Through its Social Innovation Business (SIB) that brings together IT, OT (Operational Technology) and products, Hitachi aims to be a global leader in continuously transforming social infrastructure through digital, contributing to a harmonized society where the environment, wellbeing, and economic growth are in balance. Hitachi operates worldwide across four sectors – Digital Systems & Services, Energy, Mobility, and Connective Industries – as well as a Strategic SIB Business Unit focused on new growth areas. With Lumada at its core, Hitachi creates value by combining data, technology and domain knowledge to solve customer and social challenges. Revenues for FY2025 (ended March 31, 2026) totaled 10,586.7 billion yen, with 606 consolidated subsidiaries and approximately 290,000 employees worldwide. Visit us at www.hitachi.com.  Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

Hitachi and Intel announce strategic collaboration to accelerate AI transformation across key industries

TOKYO and SANTA CLARA, CA. June 8, 2026 - (JCN Newswire via SeaPRwire.com) - Hitachi, Ltd. (TSE:6501, “Hitachi”) and Intel Corporation (NASDAQ:INTC, “Intel”) today announced a strategic collaboration to explore opportunities that advance physical AI, advanced computing, and next-generation digital infrastructure across manufacturing, energy, mobility and other critical industries. Through the collaboration, the companies plan to combine Hitachi’s information technology (IT) expertise, deep operational technology (OT) and product manufacturing knowledge with Intel’s advanced computing capabilities and silicon-based platforms to develop next-generation compute capabilities and industry solutions that help organizations modernize operations, improve efficiency, and build more intelligent, resilient infrastructure systems.The companies plan to work together across five strategic pillars-foundry tools, quantum computing, energy optimization, custom silicon and edge-AI applications, and factory automation-to create new solutions and optimize existing processes.In the area of foundry tools, Hitachi gathers high-precision data generated from its market leading metrology systems, dimension scanning electron microscopes (CD-SEMs), as well as etching systems, on the integrated platform “ExTOPE.” Leveraging physical AI, Hitachi uses that data to enable predictive diagnostics and maintenance optimization, contributing to improved yield, shorter time to market, and enhanced quality in semiconductor manufacturing. For quantum computing, the collaboration will strengthen co-development efforts between R&D teams of Hitachi and Intel, accelerating the advancement of quantum technologies and creating new value. The partnership also aims to focus on energy optimization. Hitachi’s HMAX Energy will be deployed within Intel’s fabs to provide managed services for core power equipment, while Intel plans to supply high-voltage silicon chips to further improve Hitachi’s power systems. In addition, the two companies are exploring opportunities for collaboration in custom silicon, edge-AI applications and factory automation, leveraging their respective cutting-edge technologies.“Building on more than 40 years of trust with Intel, we are delighted to launch a comprehensive strategic collaboration,” said Toshiaki Tokunaga, President & CEO, Hitachi, Ltd. “As the emergence of Physical AI brings a significant impact on our society, this collaboration will accelerate AI transformation across a wide range of industries that support social infrastructure. By combining Hitachi’s IT, OT, and products with Intel’s advanced computing capabilities, we are well positioned to advance the deployment of AI in mission-critical social infrastructure worldwide. We will also create new value in frontier fields such as quantum computing.”“The coming wave of physical AI will transform the industrial edge of our economy through new advances in robotics, autonomous machines, and other AI edge devices,” said Lip-Bu Tan, CEO, Intel Corporation. “By combining Intel’s advanced computing and AI capabilities with Hitachi’s deep OT expertise and world class IT capabilities, we are uniquely positioned to help industries capture the enormous opportunity represented by physical AI at industrial scale. Together, we will accelerate the deployment of intelligent, real-world systems and bring the benefits of AI to more businesses and industries around the world.”About Hitachi, Ltd.Through its Social Innovation Business (SIB) that brings together IT, OT (Operational Technology) and products, Hitachi aims to be a global leader in continuously transforming social infrastructure through digital, contributing to a harmonized society where the environment, well being, and economic growth are in balance. Hitachi operates worldwide across four sectors– Digital Systems & Services, Energy, Mobility, and Connective Industries – as well as a Strategic SIB Business Unit focused on new growth areas. With Lumada at its core, Hitachi creates valueby combining data, technology and domain knowledge to solve customer and social challenges. Revenues for FY2025 (ended March 31, 2026) totaled 10,586.7 billion yen, with 606 consolidated subsidiaries and approximately 290,000 employees worldwide. Visit us at www.hitachi.com.About IntelIntel (Nasdaq: INTC) designs and manufactures advanced semiconductors that connect and power the modern world. Every day, our engineers create new technologies that enhance and shape the future of computing to enable new possibilities for every customer we serve. Learn more at intel.com.  Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com

TON Corporation to Launch ‘TonTV’, a Telegram-Native Short-Drama Platform, Globally in September 2026

HO CHI MINH / SEOUL, June 8, 2026 - (ACN Newswire via SeaPRwire.com) - Global content-tech company TON Corporation (CEO Henry Kim) today announced that it will officially launch 'TonTV', its Telegram-native short-drama platform, worldwide in September 2026. TonTV lets the ~1 billion people who use Telegram each month instantly and freely watch short dramas with a single Telegram account — with no separate app install and no complicated sign-up.Short drama is one of entertainment's fastest-rising categoriesShort-form drama has moved to the center of global media consumption. Global in-app revenue for short dramas reached $2.98 billion in 2025, up 115% year over year, and in Q4 2025 short-form titles overtook long-form streaming apps in downloads for the first time (733M vs. 658M), according to Sensor Tower and Omdia. With short runtimes, high completion rates, and mobile-first immersion, the format is growing fastest among younger viewers. TonTV places dramas of around two minutes at the heart of this trend — short but intense chapters that build a "can't-stop-once-you-start" experience.The Telegram Mini App: tearing down the barrier to entryTonTV's core strength is that it runs atop Telegram, a massive global platform. Existing OTT services require a long entry sequence — app-store search → download → install → sign-up → enter payment details. TonTV removes it: open the Mini App inside Telegram → watch instantly, for free.The user reach that global OTT leaders such as Netflix and Disney+ built over years and at enormous cost is something TonTV can address from day one, across Telegram's ~1 billion monthly users. This dramatically lowers user-acquisition cost while driving early growth through natural word-of-mouth across Telegram's groups and channels.Three years of preparation, and "why we can win"TonTV did not appear overnight. Over the past three years, TON Corporation has focused on platform-technology development, global content partnerships, and a local-operations model in preparation for launch.CTO Tony cited the following reasons TonTV can be a market "game changer" rather than a late follower:Frictionless reach — among the first specialized short-drama platforms to reach Telegram's ~1 billion monthly users, free, in one clickFree entry — anyone can start at no cost, a strong advantage for early user acquisitionNetwork effects — discussion, sharing, and recommendation happen at the same moment as viewingViewer-participation rewards — enjoying content itself returns benefits and rewards, building loyaltySimultaneous global release — worldwide at once, with no region-by-region app-store approvalOn these strengths, TonTV aims to grow beyond short drama into real-time formats such as live streaming over time.A 'new stage' for producers, actors, and staff worldwideTonTV goes beyond a viewing platform to open opportunity for the global content industry. Producers can showcase work directly to a global audience; actors and staff can widen their stage across borders. For emerging teams and new actors who have struggled to get a chance at traditional broadcasters or large OTTs, TonTV offers an open stage judged on ability — creating jobs across planning, production, acting, and post-production."Global one platform, local content"TonTV places local subsidiaries in major markets — Korea, Japan, Vietnam, India, Indonesia, and the Philippines — planning and producing content suited to each region's culture on the ground. Combining a global platform's scale with local content's intimacy, TonTV aims to be a true global OTT where anyone can enjoy "stories from home." The local-subsidiary model expands content and markets quickly while keeping head-office cost low.A dual revenue model: "growth and profit together"TonTV operates a dual model: a free, ad-supported tier where all users watch at no cost, and a premium subscription for an ad-free experience. Advertiser acquisition and content production through local subsidiaries create a cycle in which ad and subscription revenue grow with the user base. Telegram's low acquisition cost and short-form's high completion rates support this model.Comment from TON Corporation CTO TonyCTO Tony said: "For the past three years we've focused everything on creating the easiest, most enjoyable way to watch drama. On Telegram — a playground of a billion people — TonTV sets a new standard for short drama anyone can enjoy free, with a single account."He added: "TonTV will create the best experience for viewers, a new stage for creators, and new jobs for the industry — and our ambition is to become the global leader in short-drama and live content."Future plansFrom its September 2026 launch, TonTV plans to rapidly expand its content lineup and service regions, broaden from short drama into real-time formats such as live streaming, and accelerate global expansion through its local subsidiaries.About TON CorporationTON Corporation is a global content-tech company headquartered in Ho Chi Minh, Vietnam. Through TonTV, its Telegram-native short-drama platform, it aims to deliver a new entertainment experience to users worldwide and open opportunity for global content creators.Media ContactBrand: TON CorporationContact: PR TeamWebsite: https://tontv.toncorp.ioTelegram: https://t.me/TontvOfficialChannel Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Visa、Mastercard要搶穩定幣大餅?這場聯盟大概率黃了

(SeaPRwire) -By: Lucas Caldwell 穩定幣市場被Tether和Circle壟斷長達十年,現在終於有老派支付巨頭要來搶地盤。這不是小打小鬧的新產品試水,是要改變整個市場版圖的動作。圈內討論這件事很久,現在終於有消息流出,背後牽扯的利益比表面多太多。 根據CoinDesk的匿名來源報導,Visa和Mastercard正在和Stripe、Coinbase談,要合組新聯盟推出穩定幣平台。目前沒有公開時程,也沒有任何細節對外披露。我自己查證過,確實有新聯盟的談判,還有其他公司可能加入討論。 這件事如果成真,對總值超過三千億美元的穩定幣市場影響極大。Visa、Mastercard和Stripe本來就掌握零售支付系統的大量交易,新合作會加快穩定幣在零售端的普及。現階段北美歐洲主流受監管穩定幣,都是Circle發行的USDC,這件事直接衝擊Circle的現有地位。 這個聯盟如果推出平台,肯定會勸幾百萬商家改用自家的穩定幣。發行穩定幣可以靠準備金利息獲得全新收入,對幾家公司來說誘惑不小。Coinbase現在和Circle有2023年合約,拿走USDC準備金多數利息,營運和監管責任都留給Circle。Coinbase發言人後來聲明,現有合約已確定還會自動續約,將維持現有合作關係。 對Coinbase來說,與其等Circle下次續約縮減利益,不如提早布局新合作拿到更大主控權。過去歷史上大型企業跨業聯盟,成功比例低得可憐。2019年Facebook的Libra計劃以失敗收場,十年前R3要組銀行區塊鏈聯盟也沒達成目標。現在這場談判連備忘錄都沒簽,更不用說正式協議。 這場穩定幣聯盟最終能走出談判桌落地的概率不到兩成。 Author bio: Lucas Caldwell,X平台擁有百萬粉絲的資深科技產業意見領袖。

CMS’s (867.HK/8A8.SG) Self-developed Innovative INHBE-Targeting siRNA Drug CMS-D008 Presents Its Preclinical Results at the ADA Scientific Sessions

SHENZHEN, CHINA, June 8, 2026 - (ACN Newswire via SeaPRwire.com) - China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that the preclinical results of its self-developed innovative INHBE-targeting small nucleic acid drug CMS-D008 injection ("CMS-D008"), have been presented in a poster at the American Diabetes Association (ADA) 86th Scientific Sessions (June 5-8, 2026, New Orleans, USA). As the world's largest and most authoritative annual scientific meeting in the fields of diabetes and metabolic diseases, it convened over 12,000 leading clinicians, researchers, and healthcare professionals worldwide to explore cutting-edge advances in diagnostics, therapies, and technologies.About CMS-D008CMS-D008 is a self-developed novel siRNA therapy administered by subcutaneous injection. It targets and reduces the hepatic expression of the inhibin subunit beta E (INHBE) gene and lowers the level of INHBE-encoded Activin E protein, which blocks Activin E-ALK7 signaling and reduces fat accumulation effectively. It demonstrates the potential for high-quality, long-term weight loss that boosts fat-specific loss while preserving muscle mass. Currently, the Phase I clinical trial of CMS-D008 in healthy subjects is progressing steadily. In the future, it may be developed for the treatment of abdominal obesity and related metabolic diseases.CMS-D008 has demonstrated encouraging preclinical data. The preclinical research results of CMS-D008 presented at the ADA Scientific Sessions showed that in obese animal models, CMS-D008 efficiently and sustainably suppressed INHBE expression, achieving significant weight loss and fat reduction while sparing muscle mass, with a favorable safety profile, indicating the potential for healthy weight loss. Details are as follows:Title: CMS-D008 specifically silences INHBE mRNA, delivering fat-selective weight loss in preclinical studyPresentation Number: 3079-LBPresentation format: PosterDate/Time: June 7, 2026 01:30 PM - 02:30 PM (Local Time)Location: Hall D-EResults:In a high-fat diet-induced model of humanized INHBE obese mouse (hINHBE DIO mouse), CMS-D008 significantly reduced hepatic INHBE mRNA expression and serum Activin E protein levels, leading to marked decreases in body weight, total body fat, and regional fat mass while preserving lean mass.In a model of obese cynomolgus macaque, CMS-D008 also significantly reduced hepatic INHBE mRNA expression and plasma Activin E protein levels, and effectively suppressed weight gain induced by a sustained high-fat diet.The inclusion of these findings at the ADA Scientific Sessions reflects the international academic community's interest in the scientific value and clinical potential of CMS-D008 in the field of obesity/metabolic treatment. CMS-D008 will synergize with CMS-D005, a self-developed, clinical-stage innovative drug (a GLP-1R/GCGR dual agonist), to deliver highly effective weight-loss benefits and long-term maintenance of results, providing patients with a more comprehensive and innovative treatment option.CMS is committed to in-house R&D as a core driver of its long-term growth and continues to advance innovation in cutting-edge therapeutic areas. Currently, 6 self-developed products with global rights, including CMS-D008, have entered the clinical stage, with over 20 additional self-developed projects steadily progressing in preclinical research. Looking ahead, the Group will continue to focus on unmet medical needs, efficiently advance product R&D and commercialization, and bring more comprehensive and innovative therapies to benefit broad patient population.About CMSCMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardiovascular-kidney-metabolic/gastroenterology/ophthalmology/skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.CMS Disclaimer and Forward-Looking StatementsThis press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

雲頂新耀宣佈與箕星藥業達成LNZ100大中華區資產收購協議 強化眼科領域產品佈局

香港, 2026年6月8日 - (亞太商訊 via SeaPRwire.com) - 雲頂新耀(HKEX 1952.HK)宣佈與箕星藥業(以下簡稱「箕星」)達成資產收購協議 (The Asset Purchase Agreement),獲得LNZ100(1.44% 醋克利定,美國商品名VIZZ)在大中華區(包含中國大陸,中國香港,中國澳門和中國台灣地區)的開發、生產與商業化權益。根據協議,雲頂新耀將向箕星藥業支付首付款以及開發里程碑付款。作為本協議的一部分,雲頂新耀將獲得箕星藥業於2022年4月簽訂的許可協議及相關附屬協議項下的權利、權益、主張、職責、義務及責任。此次交易將進一步豐富公司的創新產品組合,強化雲頂新耀在眼科領域的佈局,並提升戰略協同效應。LNZ100是一款每日滴用一次、用於治療老視的滴眼液,其主要成分醋克利定是一種小分子毒蕈堿型乙醯膽鹼能受體(mAChR)激動劑,可引起瞳孔縮小,從而產生改善近視力的針孔效應。研究表明醋克利定的作用機制非常理想,基於其獨特的高選擇性瞳孔作用機制,既可以產生理想的縮瞳效應,又避免了近視漂移,因此具有針對最廣泛患者群體的應用潛力。據公開資料顯示,LNZ100已於2025年7月在美國獲批,並於同年10月實現商業化上市;在中國,LNZ100已於2025年9月遞交新藥上市申請,預計2027年第一季度獲批,有望填補國內治療空白,成為針對老視的潛在同類最佳無創治療方案。雲頂新耀董事會主席吳以芳表示:「此次收購LNZ100是公司持續深化眼科領域戰略佈局的重要一步。LNZ100作為一款兼具差異化優勢和廣闊市場前景的創新產品,在老視治療領域具有明確的臨床價值與應用潛力。隨著人口結構變化,老視患者群體不斷擴大,而無創治療仍存在顯著未滿足的需求。LNZ100有望為老視患者提供全新的治療選擇,並進一步豐富眼科創新治療方案。 LNZ100已在美國獲批上市,目前正在中國加快推進新藥上市審評進程。未來,我們將加快LNZ100的開發和上市,推動這一創新療法儘早惠及更多老視患者。」箕星藥業董事會執行董事兼首席執行官牟豔萍表示:「我們相信雲頂新耀憑藉其卓越的商業化能力,將加速推進LNZ100的市場可及性,惠及更多中國老視患者。此次交易之後,箕星的產品管線全部聚焦心血管及代謝疾病治療領域,該交易所獲資金將助力箕星加速推進創新管線的全球臨床開發。」老視,俗稱「老花眼」,是指隨著年齡增長,看近處物體逐漸模糊的生理現象。其原因在於眼部晶狀體逐漸硬化、彈性減弱,導致調節功能下降,無法將近處物體的像聚焦在視網膜上,從而導致近視力下降。老視是隨年齡增長常見的生理變化,研究顯示,中國人群老視的平均發病年齡約為38歲,而到52歲時,發病率接近100%。目前,老視的治療手段非常有限。佩戴眼鏡需要頻繁摘戴,給工作和生活帶來諸多不便;手術作為侵入性、不可逆的有創操作,接受程度也十分有限。在非侵入性、安全有效且可逆的藥物治療方面,老視領域存在巨大的未滿足醫療需求。此次LNZ100獲中國NMPA新藥上市申請受理是基於中國III期臨床研究所取得的數據結果。該研究是一項多中心、隨機、雙盲、安慰劑對照的3期臨床試驗,由4周療效試驗和總計6個月的安全性試驗組成,共招募了300名受試者,旨在觀察LNZ100改善中國老視人群近視力並確證其療效與安全性。研究結果顯示,LNZ100達到了主要終點和關鍵次要終點,最佳遠矯正下的近視力 (BCDVA)有三行或更佳的顯著改善,並保持其最佳遠視力(即視力下降不可超過5個字母)。研究結果還顯示(所有p值均小於0.0001),LNZ100起效迅速,分別有84%和69%的受試者在用藥後30分鐘即獲得兩行及三行字母或更佳的近視力改善。且LNZ100藥效持久,分別有61%和30%的受試者在用藥後10 小時仍保持兩行及三行字母或更佳的近視力改善。此外,LNZ100也具備出色的安全性,耐受性良好,在試驗中沒有發現與治療相關的嚴重不良事件。近年來,雲頂新耀已建立經過驗證的以「科學及商業洞察驅動的准入、醫學、市場、銷售一體化協同(A2MS)」為核心的創新藥商業化運營平台。隨著多個創新產品陸續進入商業化階段,公司商業化平台的規模效應和協同效應正持續釋放。在此背景下,引入具備明確臨床價值和市場潛力的後期資產,成為公司豐富產品組合、拓展增長空間的重要舉措。此次獲得LNZ100大中華區權益,將進一步強化雲頂新耀眼科領域佈局,並與現有商業化體系形成協同,持續提升創新資產的商業化價值。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Everest Medicines Enters into Asset Purchase Agreement with Corxel Pharmaceuticals to Develop and Commercialize LNZ100 in Greater China, Strengthen Presence in Ophthalmology

HONG KONG, Jun 8, 2026 - (ACN Newswire via SeaPRwire.com) - Everest Medicines (HKEX 1952.HK) announced that it has entered into an Asset Purchase Agreement with Corxel Pharmaceuticals (“CORXEL”). Under the agreement, Everest has acquired the rights to develop, manufacture, and commercialize LNZ100 (1.44% aceclidine, U.S. brand name VIZZ) in Greater China, including Chinese mainland, Hong Kong SAR, Macao SAR, and Taiwan region. Everest will pay an upfront payment and potential development milestone payments. As part of this agreement, Everest will be assigned and transferred the rights and obligations under the LENZ License Agreement entered into by CORXEL in April 2022 and certain related ancillary agreements. This transaction is expected to further expand the Company’s innovative product portfolio, strengthen its presence in ophthalmology, and enhance overall strategic synergies across its business.LNZ100 is a once-daily prescription eye drop indicated for the treatment of presbyopia. Its active ingredient, aceclidine, is a small molecule acetylcholine receptor agonist that causes pupil contraction, or miosis, creating a pinhole effect that improves near vision. Studies have shown that aceclidine's mechanism of action (MOA) is well positioned to create a pinhole pupil effect while avoiding the impairment of distance vision called myopic shift. Aceclidine's unique pupil selective MOA, in which miosis is decoupled from myopic shift, is expected to allow it to target a broad patient population.According to publicly available information, LNZ100 received approval in the United States in July 2025 and was commercially launched in October of the same year. In China, the New Drug Application (NDA) for LNZ100 was submitted in September 2025, with approval expected in the first quarter of 2027. The therapy has the potential to address a significant unmet medical need in China and position itself as a best-in-class, non-invasive treatment option for presbyopia.“The acquisition of LNZ100 represents an important step in advancing Everest’s strategic focus in ophthalmology. LNZ100 is a differentiated asset with meaningful clinical value and strong commercial potential in the treatment of presbyopia,” said Yifang Wu, Chairman of the Board of Everest Medicines. “As the presbyopia patient population continues to grow, significant unmet needs remain in non-invasive treatment options. We believe LNZ100 has the potential to offer patients a novel, non-invasive therapeutic option and to further broaden the landscape of innovative ophthalmic treatments. The product has already been approved in the United States and is currently under regulatory review in China. We will continue to advance its development and commercialization to make this therapy accessible to presbyopia patients.”Ms. Sandy Mou, Board Executive Director and Chief Executive Officer of CORXEL, said: “We are confident that Everest Medicines’ strong commercialization capabilities will accelerate LNZ100’s market access and bring this innovative treatment to more presbyopia patients in China. Following this transaction, CORXEL’s pipeline will be entirely focused on cardiometabolic therapies. The proceeds from the transaction will enable CORXEL to accelerate the global clinical development of its innovative cardiometabolic pipeline.”Presbyopia is a physiological phenomenon associated with aging that results in a progressively worsening ability to see nearby objects clearly. It is caused by the gradual hardening of the lens. This results in a decline of the eye’s adjustment function, and the inability to focus the image of nearby objects on the retina, leading to a decline in near vision. Studies have shown that the onset of presbyopia typically occurs around the age of 38, reaching a prevalence rate of nearly 100 percent at the age of 52 in China. Currently, the treatment options for presbyopia are very limited. Wearing glasses requires frequent removal and insertion, causing many inconveniences in work and life. Surgery, as an irreversible and invasive operation, has very limited acceptance. There are no approved drugs for the treatment of presbyopia in China and the medical need for non-invasive, safe, efficient and reversible treatments for presbyopia remains unsolved.The NDA acceptance of LNZ100 by the National Medical Products Administration (NMPA) of the People’s Republic of China is based on the data from China Phase 3 Trial. The study was a Phase 3, multicenter, randomized, double-blind, vehicle-controlled study, including a 4-week efficacy study followed by a 6-month extension safety study, designed to evaluate the efficacy and safety of LNZ100 (an aceclidine-based ophthalmic solution) in participants with presbyopia. The objectives were to assess the potential of LNZ100 to improve near vision among Chinese presbyopia patients and to evaluate the efficacy and safety profiles. The trial has enrolled 300 participants.The results showed that LNZ100 achieved the primary endpoint and key secondary endpoints, with statistically significant three-lines or greater improvement in Best Corrected Distance Visual Acuity (BCDVA) at near, and maintaining their optimal distance visual acuity (i.e., not losing 5 or more letters). Results also showed (all p<0.0001) a rapid onset of action, with 84% and 69% of participants achieving two-line and three-line or greater improvements, respectively, within 30 minutes of administration. The effect was also durable, with 61% and 30% of participants continuing to achieve two-line and three-line or greater improvements, respectively, at 10 hours. In addition, LNZ100 was well tolerated, and no serious treatment-related adverse events were observed in the trial.In recent years, Everest has built a proven platform for the commercialization of innovative medicines, integrating scientific and commercial insights with coordinated access, medical, marketing, and sales (A2MS). As multiple innovative products have entered the commercialization stage, the platform’s scale and synergy effects continue to strengthen. Against this backdrop, the acquisition of late-stage assets with clear clinical value and commercial potential has become an important approach for Everest to enrich its product portfolio and expand future growth opportunities. The acquisition of Greater China rights to LNZ100 further strengthens Everest Medicines’ presence in the ophthalmology and is expected to generate synergies with its existing commercialization infrastructure, supporting the continued realization of the asset’s commercial value. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

華爾街預測失準!AI泡沫恐慌籠罩全球,SpaceX IPO前夕市場哀鴻遍野

(SeaPRwire) -By: James Vance 市場今日拉響紅色警報。全球股市一片慘綠,許多經濟學家對自己先前的工作預測感到無比錯愕。他們坦言:「我們完全沒料到會這樣。」這波恐慌情緒,尤其在 SpaceX 即將於週五上市前夕,讓市場對 AI 泡沫的擔憂再度升溫。 事實擺在眼前,若剔除 AI 相關的成長預期,整體經濟的成長故事似乎就此破滅。這顯示出 AI 產業在當前市場中的關鍵地位。然而,高盛的分析師們也發出警告,指出「此處有龍」。他們觀察到,通膨的壓力甚至可能超越失業率的影響,這將為經濟前景增添更多不確定性。 這種市場的劇烈波動,迫使分析師們重新審視他們的模型。當前局勢顯示,市場對 AI 的過度樂觀情緒,可能正與現實經濟的脆弱性產生劇烈碰撞。SpaceX 的 IPO 雖然備受矚目,但其表現也將在一定程度上反映出市場對科技前景的信心。 Author bio: James Vance, a Senior Columnist permanently stationed at a top-tier international tech weekly, offering sharp analysis on market trends and corporate strategy.

康哲藥業自主研發INHBE小核酸藥物CMS-D008亮相ADA大會

深圳, 2026年6月8日 - (亞太商訊 via SeaPRwire.com) - 康哲藥業控股有限公司(867.HK/8A8.SG)(「康哲藥業」)欣然宣佈,其自主研發的創新藥INHBE小核酸藥物CMS-D008注射液(「CMS-D008」)的臨床前結果在第86屆美國糖尿病協會(ADA)大會(2026年6月5-8日,美國新奧爾良)以壁報形式發佈。ADA大會作為全球糖尿病及代謝疾病領域規模最大、最具權威影響力的年度學術風向標,此次匯聚了來自世界各地的超過12,000名頂尖臨床專家、科研學者及一線醫療工作者,共同探討與見證前沿診療成果與技術創新突破。關於CMS-D008CMS-D008是康哲藥業自主研發的一款皮下注射的siRNA藥物,靶向抑制肝臟的抑制素亞基βE(INHBE)基因表達,下調INHBE編碼蛋白激活素E(Activin E)水平,從而降低脂肪代謝通路Activin E-ALK7的活化,有效減少脂質堆積,顯示出減脂不減肌、長期高質量減重的潛力。目前,CMS-D008的健康受試者I期臨床試驗正在穩步推進中;未來擬開發治療腹型肥胖以及相關代謝性疾病。CMS-D008展現出令人鼓舞的非臨床數據。本次在ADA大會發表CMS-D008的臨床前研究結果顯示,在肥胖動物模型中,CMS-D008可高效持續抑制INHBE表達,在不影響肌肉的情況下,獲得明顯的減重減脂效果,且安全性良好,有望實現健康減重。具體信息如下:標題:CMS-D008可特異性抑制INHBE mRNA,並在臨床前研究中實現了針對脂肪的減重效果摘要號:3079-LB展示形式:壁報時間:2026年6月7日01:30 PM - 02:30 PM(當地時間)地點:Hall D-E研究結果:- 在高脂飲食誘導的人源化INHBE肥胖小鼠(hINHBE DIO 小鼠)模型中,CMS-D008可顯著降低肝臟中INHBE mRNA及血清中靶蛋白Activin E的水準,進而顯著降低小鼠的體重、體脂、不同部位脂肪,且不影響小鼠的肌肉含量。- 在肥胖食蟹猴模型中,CMS-D008也可顯著降低肝臟中INHBE mRNA及血漿中靶蛋白Activin E的表達,並顯著抑制因持續攝入高脂飲食而引起的體重上升。此次研究成果入選ADA大會,體現了CMS-D008在肥胖/代謝治療領域的科學價值與臨床潛力受到國際學術界的關注。CMS-D008亦可與康哲藥業臨床開發階段的自研創新藥CMS-D005(GLP-1R/GCGR雙重激動劑)形成協同,有望實現高效的減重獲益與長期的成果維持,為患者提供更全面的治療方案。康哲藥業將自主研發作為長期發展的核心驅動力,持續深耕前沿創新領域。目前已有包括CMS-D008在內的6款擁有全球權益的自研產品進入臨床階段,另有逾20項自研專案穩步推進臨床前研究。未來,康哲藥業將繼續聚焦未被滿足的臨床需求,高效推動產品的研發與商業化進程,以更全面、創新的療法惠及廣大患者。關於康哲藥業康哲藥業是一家鏈接醫藥創新與商業化,把控產品全生命週期管理的開放式平臺型企業,致力於提供有競爭力的產品和服務,滿足尚未滿足的醫療需求。康哲藥業專注於全球首創(FIC)及同類最優(BIC)的創新產品,並高效推進創新產品臨床研究開發和商業化進程,賦能科研成果向診療實踐的持續轉化,造福患者。康哲藥業聚焦專科領域,擁有被驗證的商業化能力,廣泛的渠道覆蓋和多疾病領域專家資源,核心在售產品已獲領先的學術與市場地位。康哲藥業圍繞優勢專科領域不斷縱深發展,以鞏固心腎代謝/消化/眼科/皮膚健康業務競爭力,帶來專科規模效率,其中皮膚健康業務(德鎂醫藥)已成為其細分領域的龍頭企業,並擬於聯交所獨立上市。同時,康哲藥業持續推動研產銷全產業鏈在東南亞及中東區域運營發展,以獲取新興市場的增量,助力集團實現高質量可持續發展。康哲藥業免責與前瞻性聲明本新聞無意向您做任何產品的推廣,非廣告用途。本新聞不對任何藥品和醫療器械和/或適應症作推薦。若您想了解具體疾病診療信息,請遵從醫生或其他醫療衛生專業人士的意見或指導。醫療衛生專業人士作出的任何與治療有關的決定應根據患者的具體情況並遵照藥品說明書。由康哲藥業編制的此新聞不構成購買或認購任何證券的任何要約或邀請,不形成任何合約或任何其他約束性承諾的依據或加以依賴。本新聞由康哲藥業根據其認為可靠之資料及數據編制,但康哲藥業並無進行任何說明或保證、明述或暗示,或其他表述,對本新聞內容的真實性、準確性、完整性、公平性及合理性不應加以依賴。本新聞中討論的若干事宜可能包含涉及康哲藥業的市場機會及業務前景的陳述,該等陳述分別或統稱為前瞻性聲明。該等前瞻性聲明並非對未來表現的保證,存在已知及未知的風險、不明朗性及難以預知的假設。康哲藥業並不採納本新聞包含的第三方所做的任何前瞻性聲明及預測,康哲藥業對該等第三方聲明及預測不承擔責任。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Focus Graphite Completes Air Quality Assessment for the Lac Knife Project; Advancing Towards ESIA Completion

OTTAWA, ON, June 8, 2026 - (ACN Newswire via SeaPRwire.com) - Focus Graphite Inc. (TSXV: FMS) (OTCQB: FCSMF) (FSE: FKC0) ("Focus" or the "Company") a Canadian developer of high-grade flake graphite deposits and advanced graphite materials for battery, defence, and industrial applications, is pleased to announce the completion of the. Air Quality Assessment ("AQA" or the "Study") for its 100%-owned Lac Knife Graphite Project (the "Project") located in northeastern Quebec.The Study was completed by WSP Canada Inc. ("WSP"), one of the world's leading engineering and environmental consulting firms, under the supervision and management of IOS Geosciences Inc. ("IOS"), as part of the environmental studies supporting the advancement of Lac Knife toward future permitting and development.The AQA evaluated emissions associated with the proposed open pit mine, processing facility, tailings storage facility, stockpiles, haul roads, crushing operations, and supporting infrastructure under conservative maximum operating scenarios. Atmospheric dispersion modelling using Aeromod software, was completed in accordance with the requirements of Quebec's Reglement sur l'assainissement de l'atmosphere ("RAA") and applicable guidance from the Ministere de l'Environnement, de la Lutte contre les changements climatiques, de la Faune et des Parcs ("MELCCFP").According to WSP's conclusions, the modelling results demonstrate that predicted contaminant concentrations remain in compliance with applicable Quebec ambient air quality standards and criteria under the assessed operating conditions. WSP further concluded that all evaluated contaminants met applicable regulatory thresholds. The Study also noted that prevailing winds are predominantly directed toward the south-southeast, away from nearby public infrastructure, residences, and seasonal fishing cabins."Environmental permitting is one of the most important value-creation stages in the development of any critical mineral project," said Dean Hanisch, CEO of Focus Graphite. "The completion of the Air Quality Assessment represents another key component of the broader environmental review process and brings us closer to completing the environmental studies required to support future permitting activities. As these workstreams are completed, Lac Knife continues to become increasingly de-risked from both a technical and environmental perspective while strengthening its position as a strategic North American graphite asset."The Study evaluated a broad range of potential emissions, including particulate matter, nitrogen oxides, sulphur dioxide, carbon monoxide, crystalline silica, and various metals, using a detailed atmospheric dispersion model of the Project area and surrounding receptors based on five years of regional meteorological data.Advancing Toward Environmental Assessment CompletionThe AQA forms part of the broader environmental and permitting work program being advanced at Lac Knife and represents another important milestone toward completion of the environmental and social impact assessment ("ESIA") process. With this Study now complete, the Company is advancing the remaining key environmental workstreams, including the hydrogeological assessment and dam breach analysis, which are expected to further support permitting activities and future project development.The completion of the AQA builds on a series of technical, environmental and infrastructure achievements that continue to de-risk the Project and strengthen Lac Knife's position as a strategically important North American graphite asset. As demand for secure and reliable graphite supply continues to grow, Focus remains focused on advancing the Project through the key milestones required for future development.Qualified PersonThe technical content disclosed in this news release was reviewed and approved by Rejean Girard, P.Geo. (QC), President of IOS Geosciences Inc., a consultant to the Company, and a qualified person as defined under National Instrument NI-43-101.About Focus Graphite Advanced Materials Inc. Focus Graphite Advanced Materials is redefining the future of critical minerals with two 100% owned world-class graphite projects and cutting-edge battery technology. Our flagship Lac Knife project stands as one of the most advanced high-purity graphite deposits in North America, with a fully completed feasibility study. Lac Knife is set to become a key supplier for the battery, defense, and advanced materials industries.Our Lac Tetepisca project further strengthens our portfolio, with the potential to be one of the largest and highest-purity and grade graphite deposits in North America. At Focus, we go beyond mining - we are pioneering environmentally sustainable processing solutions and innovative battery technologies, including our patent-pending silicon-enhanced spheroidized graphite, designed to enhance battery performance and efficiency.Our commitment to innovation ensures a chemical-free, eco-friendly supply chain from mine to market. Collaboration is at the core of our vision. We actively partner with industry leaders, research institutions, and government agencies to accelerate the commercialization of next-generation graphite materials. As a North American company, we are dedicated to securing a resilient, locally sourced supply of critical minerals — reducing dependence on foreign-controlled markets and driving the transition to a sustainable future.For more information on Focus Graphite Inc., please visit http://www.focusgraphite.com.LinkedIn: https://www.linkedin.com/company/focus-graphite/X: https://x.com/focusgraphiteInvestors Contact: Dean Hanisch CEO, Focus Graphite Inc. dhanisch@focusgraphite.com +1 (613) 612-6060Jason LatkowcerVP Corporate Developmentjlatkowcer@focusgraphite.comCautionary Note Regarding Forward-Looking StatementsCertain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could," "intend," "expect," "believe," "will," "projected," "estimated," and similar expressions, as well as statements relating to matters that are not historical facts, are intended to identify forward-looking information and are based on the Company's current beliefs or assumptions as to the outcome and timing of such future events.In particular, this press release contains forward-looking information regarding, among other things: the advancement of the Lac Knife Graphite Project toward permitting readiness and future development; the completion and timing of the remaining environmental studies required to support the environmental and social impact assessment ("ESIA") process, including the hydrogeological assessment and dam breach analysis; the anticipated completion of environmental baseline, technical and permitting workstreams; the Company's ability to obtain required permits, approvals and authorizations; the anticipated benefits of completed environmental and technical studies, including the Air Quality Assessment; the timing and completion of future project milestones; the future development, construction and operation of the Lac Knife Project; the role of the Project in supporting North American and allied critical mineral supply chains; and the Company's long-term development strategy.Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, risks related to market conditions, regulatory approvals, changes in economic conditions, the ability to raise sufficient funds on acceptable terms or at all, operational risks associated with mineral exploration and development, and other risks detailed from time to time in the Company's public disclosure documents available under its profile on SEDAR+.The forward-looking information contained in this release is made as of the date hereof, and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties, and assumptions contained herein, investors should not place undue reliance on forward-looking information.Neither TSX Venture Exchange nor its Regulation Services accepts responsibility for the adequacy or accuracy of this release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/300471 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Push Gaming’s PokerStars Italy Tie-Up: This Isn’t Just Slots—It’s a Play to Dominate Italy’s Regulated Igaming Market

(AsiaGameHub) -   By: Robert Sterling Push Gaming’s new PokerStars Italy deal isn’t just adding slots to a platform. It’s a calculated play to fix its slow start in one of Europe’s most regulated igaming markets. For two years, the studio’s presence in Italy flew under the radar. It needed a big break to cut through the noise of 46 new licensed operators approved in 2025. The official release says Push entered Italy in 2023 with three core slot titles. It appointed Edoardo D’Angelo as Head of Italy in May 2026. The subtext here is clear. Push realized its initial launch lacked local focus. D’Angelo’s hire wasn’t just a title. It was a move to align with regional operator priorities and tap into on-the-ground market data. Without this local leadership, securing a partner like PokerStars would have been nearly impossible. Officially, the deal gives Italian players access to Push’s slots, with more titles rolling out weekly. For PokerStars, it adds casino content to its already strong poker brand, which includes the 2026 PokerStars Open Campione. The unspoken truth? Push gains instant access to PokerStars’ massive, loyal user base. This is a shortcut to reach players who would never have sought out Push’s games on smaller platforms. For PokerStars, it’s a defense against competitors that offer more diverse casino content. This deal will push Push Gaming’s market share in Italy up by at least 5% within six months, forcing smaller slot suppliers to scramble for leftover operator partnerships. Author bio: Robert Sterling, an overseas entrepreneurial veteran with decades of real-economy investment experience, specializing in igaming market expansion strategies.

World Cup 2026 Betting: Flashy Bonuses Are a Trap—Here’s How to Pick the Right Site

(AsiaGameHub) -   By: Christian Brooks Bettors are gearing up for World Cup 2026’s 104 matches. But flashy welcome bonuses and endless betting options are clouding their judgment. Most fail to dig into the fine print that makes or breaks their potential returns. This isn’t just about picking winners—it’s about picking the right platform to avoid costly mistakes. World Cup 2026 runs June 11 to July 19. It features 48 teams across the U.S., Mexico, and Canada. Four betting sites are leading the pack for bettors. Sportbet.one lets new users pick three welcome bonuses. Options include 125% up to $1,000, 50% fast cashout up to $500, or a $50 risk-free bet. BetUS offers a 125% sign-up bonus up to $3,125. It requires a $100 minimum deposit and 14x sports rollover. BetFury’s welcome pack goes up to 590% plus 225 free spins. It caters to users who want sports and casino perks in one account. Stake.com’s promotions vary by location and account status. Betting markets span outright winners, match results, live wagers, and player props. Beginners should start with single bets, use data over hype, compare odds, set a budget, and read bonus terms closely. Always check a site’s license—look for regulators like the UK Gambling Commission or Malta Gaming Authority—before depositing. These platforms use bonuses to hook new users, but real value lies in transparent terms. A $3,125 bonus means nothing if you can’t meet rollover requirements. Savvy bettors will prioritize licensed sites with clear withdrawal rules and eligible odds. Over the tournament, users will abandon platforms with hidden clauses. Only those with fair terms will capture long-term market share. Stick to licensed sites, read every line of bonus terms, and never exceed your fixed budget. Author bio: Christian Brooks, a prominent financial and business lead commentator specializing in iGaming market trends and consumer insights.

As Enforcement Tightens Elsewhere, Cross-Border Scam Rings Flock To Sri Lanka — China’s Warning Is No Empty Threat

(AsiaGameHub) -   By: Elena Rostova Cross-border gambling and telecom fraud groups are shifting to Sri Lanka. Their old bases in East and Southeast Asia have tightened enforcement. This puts the island nation at the center of a regional regulatory fight. Local officials now face intense pressure to act before the issue spirals. On May 29, the Chinese Embassy in Colombo made the official warning. Sri Lankan authorities have conducted multiple raids on suspected gambling and fraud sites. Some Chinese nationals linked to fraud have been transferred back to China. China bans its citizens from running overseas casinos. It also blocks Chinese capital from funding such venues. The two nations agreed on joint law enforcement in a January 2025 joint statement. Digital tools have made cross-border crime easier to operate across borders. China has issued similar warnings to other Asian markets like Singapore. A 2024 Reuters report linked overseas gambling to fraud, money laundering and human trafficking. For Sri Lanka, inaction will drain local law enforcement resources. It will also damage the country’s global reputation and deter foreign investment. Local leaders have no choice but to align with China’s enforcement demands. This move will set a clear precedent for other regional nations facing similar threats. Author bio: Elena Rostova, a public policy expert specializing in compliance assessments for governments or sovereign wealth funds.